• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重再生障碍性贫血作为经典型霍奇金淋巴瘤的首发表现

Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma.

作者信息

Pedrosa Cláudia L, Rosinha Patrícia, Seabra Patrícia, Ferreira Gisela, Rosado Cláudia, Regadas Luísa, Casais Cláudia, Coutinho Jorge

机构信息

Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.

Department of Internal Medicine, Centro Hospitalar Do Baixo Vouga, Aveiro, Portugal.

出版信息

Case Rep Hematol. 2021 Feb 9;2021:8876249. doi: 10.1155/2021/8876249. eCollection 2021.

DOI:10.1155/2021/8876249
PMID:33628540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7886563/
Abstract

Autoimmune cytopenia, a known paraneoplastic complication of lymphoid neoplasms, may occur before, concurrently, at relapse, or even years after completion of lymphoma treatment. In the case of Hodgkin lymphoma (HL), it is thought that immune dysregulation, typical of this neoplasm, may be involved in the genesis of these manifestations. We report a 57-year-old male presenting with stage IIIA, International Prognostic Score (IPS) 4, nodular sclerosis HL, and severe AA (SAA) confirmed on the histologic exam of the bone marrow that showed severe marrow hypoplasia due to a decrease in the elements of the three cell linages with left shift of the myeloid maturation. Immunosuppression with steroids and cyclosporine A was started. Eltrombopag and G-CSF were also added. In spite of prompt initiation of immunosuppressive therapy, the patient presented an unfavorable outcome with progressive pancytopenia and severe acute cerebral hemorrhagic event. The patient died 59 days after admission. Although autoimmune disorders are described in HL, its concomitant diagnosis is extremely rare. Our case shows a rare instance of SAA as the first manifestation of HL.

摘要

自身免疫性血细胞减少是一种已知的淋巴系统肿瘤副肿瘤性并发症,可发生在淋巴瘤治疗前、治疗期间、复发时,甚至在淋巴瘤治疗结束数年之后。对于霍奇金淋巴瘤(HL)而言,人们认为这种肿瘤典型的免疫失调可能与这些表现的发生有关。我们报告了一名57岁男性,其表现为ⅢA期、国际预后评分(IPS)为4、结节硬化型HL,骨髓组织学检查确诊为严重再生障碍性贫血(SAA),显示由于三系细胞成分减少且髓系成熟左移导致严重骨髓增生低下。开始使用类固醇和环孢素A进行免疫抑制治疗。还加用了艾曲泊帕和粒细胞集落刺激因子(G-CSF)。尽管迅速启动了免疫抑制治疗,但患者病情预后不佳,出现进行性全血细胞减少和严重的急性脑出血事件。患者入院59天后死亡。虽然HL中描述了自身免疫性疾病,但其同时诊断极为罕见。我们的病例显示了SAA作为HL首发表现的罕见情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/7886563/d65811909e32/CRIHEM2021-8876249.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/7886563/a1b715b0de77/CRIHEM2021-8876249.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/7886563/d65811909e32/CRIHEM2021-8876249.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/7886563/a1b715b0de77/CRIHEM2021-8876249.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/7886563/d65811909e32/CRIHEM2021-8876249.002.jpg

相似文献

1
Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma.严重再生障碍性贫血作为经典型霍奇金淋巴瘤的首发表现
Case Rep Hematol. 2021 Feb 9;2021:8876249. doi: 10.1155/2021/8876249. eCollection 2021.
2
Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes.霍奇金淋巴瘤伴再生障碍性贫血及大颗粒淋巴细胞多克隆扩增。
Acta Haematol. 2007;117(4):238-41. doi: 10.1159/000100038. Epub 2007 Feb 23.
3
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.艾曲泊帕添加至标准免疫抑制方案用于治疗再生障碍性贫血
N Engl J Med. 2017 Apr 20;376(16):1540-1550. doi: 10.1056/NEJMoa1613878.
4
Novel therapeutic choices in immune aplastic anemia.免疫性再生障碍性贫血的新型治疗选择
F1000Res. 2020 Sep 10;9. doi: 10.12688/f1000research.22214.1. eCollection 2020.
5
Disappearance of monosomy 7 in a patient with aplastic anemia after eltrombopag treatment.艾曲泊帕治疗后再生障碍性贫血患者7号染色体单体消失。
Hematology. 2020 Dec;25(1):165-167. doi: 10.1080/16078454.2020.1757331.
6
[Autoimmune hemolytic anemia and immune thrombocytopenia associated with Hodgkin disease: Retrospective monocentric study].[与霍奇金病相关的自身免疫性溶血性贫血和免疫性血小板减少症:回顾性单中心研究]
Rev Med Interne. 2019 Dec;40(12):785-790. doi: 10.1016/j.revmed.2019.03.328. Epub 2019 Oct 24.
7
Special Education: Aplastic Anemia.特殊教育:再生障碍性贫血。
Oncologist. 1996;1(3):187-189.
8
Immunocompetent Patient With Primary Bone Marrow Hodgkin Lymphoma.原发性骨髓霍奇金淋巴瘤免疫功能正常患者。
J Med Cases. 2022 Sep;13(9):427-431. doi: 10.14740/jmc3973. Epub 2022 Sep 28.
9
Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.再生障碍性贫血患者的免疫抑制治疗:一项单中心回顾性研究。
PLoS One. 2015 May 13;10(5):e0126925. doi: 10.1371/journal.pone.0126925. eCollection 2015.
10
Adult T-type lymphoblastic lymphoma presenting as hypercalcemic crisis and aplastic anemia: a case report.成人T型淋巴细胞淋巴瘤表现为高钙血症危象和再生障碍性贫血:一例报告
J Med Case Rep. 2019 Oct 8;13(1):305. doi: 10.1186/s13256-019-2225-2.

本文引用的文献

1
Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.霍奇金淋巴瘤患者发生特发性获得性再生障碍性贫血的风险增加。
PLoS One. 2019 Apr 5;14(4):e0215021. doi: 10.1371/journal.pone.0215021. eCollection 2019.
2
Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.再生障碍性贫血与淋巴瘤的关联:欧洲血液与骨髓移植学会重型再生障碍性贫血工作组的报告
Br J Haematol. 2019 Jan;184(2):294-298. doi: 10.1111/bjh.15074. Epub 2017 Dec 19.
3
Aplastic anemia: possible associations with lymphoproliferative neoplasms.
再生障碍性贫血:可能与淋巴增生性肿瘤相关。
Int J Lab Hematol. 2014 Jun;36(3):382-7. doi: 10.1111/ijlh.12224.
4
Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.霍奇金淋巴瘤相关的副肿瘤性自身免疫性血细胞减少症。
Leuk Lymphoma. 2010 Mar;51(3):469-74. doi: 10.3109/10428190903556394.
5
Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes.霍奇金淋巴瘤伴再生障碍性贫血及大颗粒淋巴细胞多克隆扩增。
Acta Haematol. 2007;117(4):238-41. doi: 10.1159/000100038. Epub 2007 Feb 23.
6
Immunobiology and pathophysiology of Hodgkin lymphomas.霍奇金淋巴瘤的免疫生物学与病理生理学
Hematology Am Soc Hematol Educ Program. 2005:231-8. doi: 10.1182/asheducation-2005.1.231.